Handelen Catalent Inc - CTLT CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.42 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.030779% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.013666% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Catalent Inc ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Belangrijkste statistieken
| Prev. Close* | 66.68 |
| Open* | 67.41 |
| 1-Jaarlijkse Verandering* | -34.76% |
| Dagelijks bereik* | 67.41 - 72.27 |
| 52 wekelijks bereik | 40.69-115.34 |
| Weekgemiddelde volume (10 dagen) | 2.47M |
| Gemiddeld volume (3 maanden) | 60.37M |
| Marktkapitalisatie | 10.09B |
| P/E Ratio | 23.98 |
| Uitstaande Aandelen | 179.96M |
| Omzet | 4.83B |
| EPS | 2.34 |
| Dividend (opbrengst %) | N/A |
| Beta | 1.25 |
| Volgende inkomsten datum | Feb 7, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | 66.68 | -1.96 | -2.86% | 68.64 | 69.86 | 66.16 |
| Feb 3, 2023 | 55.95 | 1.05 | 1.91% | 54.90 | 57.39 | 54.60 |
| Feb 2, 2023 | 56.52 | 1.82 | 3.33% | 54.70 | 57.83 | 54.70 |
| Feb 1, 2023 | 54.61 | 1.33 | 2.50% | 53.28 | 54.68 | 51.72 |
| Jan 31, 2023 | 53.42 | 0.70 | 1.33% | 52.72 | 53.45 | 52.12 |
| Jan 30, 2023 | 52.46 | 0.11 | 0.21% | 52.35 | 54.20 | 52.35 |
| Jan 27, 2023 | 53.50 | 2.05 | 3.98% | 51.45 | 53.99 | 51.45 |
| Jan 26, 2023 | 52.14 | 1.97 | 3.93% | 50.17 | 52.20 | 50.17 |
| Jan 25, 2023 | 50.04 | 1.17 | 2.39% | 48.87 | 50.07 | 48.03 |
| Jan 24, 2023 | 49.43 | -1.92 | -3.74% | 51.35 | 51.46 | 48.84 |
| Jan 23, 2023 | 52.46 | 3.37 | 6.86% | 49.09 | 52.54 | 48.65 |
| Jan 20, 2023 | 49.32 | 0.30 | 0.61% | 49.02 | 49.45 | 48.19 |
| Jan 19, 2023 | 49.17 | 1.78 | 3.76% | 47.39 | 49.69 | 46.48 |
| Jan 18, 2023 | 48.05 | 0.19 | 0.40% | 47.86 | 49.14 | 47.86 |
| Jan 17, 2023 | 47.83 | -0.58 | -1.20% | 48.41 | 48.70 | 47.18 |
| Jan 13, 2023 | 48.93 | 0.68 | 1.41% | 48.25 | 49.18 | 47.70 |
| Jan 12, 2023 | 49.24 | 0.15 | 0.31% | 49.09 | 49.42 | 48.31 |
| Jan 11, 2023 | 49.30 | 0.57 | 1.17% | 48.73 | 50.19 | 48.25 |
| Jan 10, 2023 | 47.95 | 0.40 | 0.84% | 47.55 | 48.88 | 47.55 |
| Jan 9, 2023 | 48.06 | 0.36 | 0.75% | 47.70 | 48.93 | 47.70 |
Catalent Inc Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 1848.1 | 2075.4 | 2463.4 | 2518 | 3094.3 | 3998 |
| Inkomsten | 1848.1 | 2075.4 | 2463.4 | 2518 | 3094.3 | 3998 |
| Kosten van opbrengsten, totaal | 1260.5 | 1420.8 | 1710.8 | 1712.9 | 2111 | 2646 |
| Brutowinst | 587.6 | 654.6 | 752.6 | 805.1 | 983.3 | 1352 |
| Totale bedrijfskosten | 1630.3 | 1845.5 | 2204.1 | 2259.9 | 2716.2 | 3188 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 350.5 | 395.6 | 456.3 | 508.7 | 575.3 | 687 |
| Onderzoek & Ontwikkeling | 7.6 | 7 | 6.3 | 3.3 | 2.6 | |
| Ongebruikelijke uitgaven (inkomsten) | 11.7 | 22.1 | 30.7 | 35 | 27.3 | -164 |
| Bedrijfsresultaat | 217.8 | 229.9 | 259.3 | 258.1 | 378.1 | 810 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -75.9 | -94.3 | -106.8 | -110.4 | -123.1 | -115 |
| Overige, Netto | 3 | 0 | -0.5 | 12.6 | 5.4 | 20 |
| Netto inkomen voor belastingen | 144.9 | 135.6 | 152 | 160.3 | 260.4 | 715 |
| Netto inkomen na belastingen | 111.2 | 109.8 | 126.2 | 137.4 | 220.7 | 585 |
| Minderheidsbelang | 0.3 | 0 | 0 | |||
| Netto inkomen voor extra. Posten | 111.5 | 109.8 | 126.2 | 137.4 | 220.7 | 585 |
| Totale buitengewone posten | 0 | 0 | -42.6 | |||
| Netto inkomen | 111.5 | 109.8 | 83.6 | 137.4 | 220.7 | 585 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 111.5 | 109.8 | 126.2 | 137.4 | 173 | 529 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 111.5 | 109.8 | 83.6 | 137.4 | 173 | 529 |
| Verwaterd Netto Inkomen | 111.5 | 109.8 | 83.6 | 137.4 | 173 | 529 |
| Verwaterd Gewogen Gemiddelde Aandelen | 125.87 | 126.738 | 133.201 | 145.954 | 152.322 | 170 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.88583 | 0.86636 | 0.94744 | 0.94139 | 1.13575 | 3.11176 |
| Dividends per Share - Common Stock Primary Issue | 0 | |||||
| Verwaterde Genormaliseerde Winst per Aandeel | 0.95717 | 1.00755 | 1.1388 | 1.14693 | 1.28765 | 2.4139 |
| Total Adjustments to Net Income | -47.7 | -56 | ||||
| Other Operating Expenses, Total | 19 |
| Q3 2021 | Q4 2021 | Q1 2021 | Q2 2021 | Q3 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 1053.3 | 1188.2 | 1025 | 1217 | 1273 |
| Inkomsten | 1053.3 | 1188.2 | 1025 | 1217 | 1273 |
| Kosten van opbrengsten, totaal | 687.7 | 748.9 | 701 | 812 | 850 |
| Brutowinst | 365.6 | 439.3 | 324 | 405 | 423 |
| Totale bedrijfskosten | 701.9 | 937.7 | 891 | 1056 | 1062 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 172.7 | 184.1 | 183 | 228 | 207 |
| Ongebruikelijke uitgaven (inkomsten) | -158.5 | 2.8 | 3 | 0 | 0 |
| Bedrijfsresultaat | 351.4 | 250.5 | 134 | 161 | 211 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -33.8 | -30.8 | -35 | -47 | -37 |
| Overige, Netto | -0.5 | 1.8 | 4 | 1 | 2 |
| Netto inkomen voor belastingen | 317.1 | 221.5 | 103 | 115 | 176 |
| Netto inkomen na belastingen | 231.8 | 182.4 | 93 | 97 | 141 |
| Netto inkomen voor extra. Posten | 231.8 | 182.4 | 93 | 97 | 141 |
| Netto inkomen | 231.8 | 182.4 | 93 | 97 | 141 |
| Total Adjustments to Net Income | -14.7 | -13.5 | -9 | -4 | 0 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 217.1 | 168.9 | 84 | 93 | 141 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 217.1 | 168.9 | 84 | 93 | 141 |
| Verwaterd Netto Inkomen | 217.1 | 168.9 | 84 | 93 | 141 |
| Verwaterd Gewogen Gemiddelde Aandelen | 172.5 | 171.5 | 172 | 177 | 181 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 1.25855 | 0.98484 | 0.48837 | 0.52542 | 0.77901 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
| Verwaterde Genormaliseerde Winst per Aandeel | 0.58688 | 1.00741 | 0.52512 | 0.60644 | 0.80114 |
| Other Operating Expenses, Total | 1.9 | 4 | 16 | 5 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 790.2 | 1059.8 | 1240.3 | 1395.8 | 2293 | 2918 |
| Geldmiddelen en kortetermijnbeleggingen | 131.6 | 306.9 | 410.2 | 345.4 | 953.2 | 967 |
| Geldmiddelen & Equivalenten | 131.6 | 288.3 | 410.2 | 345.4 | 953.2 | 896 |
| Totale Vorderingen, Netto | 414.8 | 488.8 | 555.8 | 716.4 | 899.5 | 1193 |
| Accounts Receivable - Trade, Net | 414.8 | 488.8 | 555.8 | 716.4 | 899.5 | 1193 |
| Total Inventory | 165.6 | 196.7 | 220.2 | 265.3 | 346.9 | 593 |
| Prepaid Expenses | 36.1 | 23.8 | 38.9 | 45.1 | 62.6 | 118 |
| Other Current Assets, Total | 42.1 | 43.6 | 15.2 | 23.6 | 30.8 | 47 |
| Total Assets | 3091.1 | 3454.3 | 4531.1 | 6184 | 7776.5 | 9112 |
| Property/Plant/Equipment, Total - Net | 905.8 | 995.9 | 1270.6 | 1536.7 | 2002.2 | 2608 |
| Property/Plant/Equipment, Total - Gross | 1550.7 | 1707.7 | 2097.9 | 2450.1 | 3046.8 | 3787 |
| Accumulated Depreciation, Total | -644.9 | -711.8 | -827.3 | -913.4 | -1044.6 | -1179 |
| Goodwill, Net | 996.5 | 1044.1 | 1397.2 | 2220.9 | 2470.6 | 2519 |
| Intangibles, Net | 294 | 273.1 | 544.9 | 930.8 | 888.7 | 817 |
| Other Long Term Assets, Total | 104.6 | 81.4 | 78.1 | 99.8 | 122 | 250 |
| Total Current Liabilities | 391.2 | 469 | 576.9 | 670.7 | 893.2 | 1196 |
| Accounts Payable | 143.7 | 163.2 | 192.1 | 255.8 | 321 | 385 |
| Accrued Expenses | 134.8 | 171.6 | 186.1 | 174.7 | 303.8 | 401 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 27.7 | 24.6 | 71.9 | 76.5 | 72.9 | 75 |
| Other Current Liabilities, Total | 85 | 109.6 | 126.8 | 163.7 | 195.5 | 335 |
| Total Liabilities | 2455.2 | 2730.8 | 3444.4 | 3895.8 | 4271.1 | 4838 |
| Total Long Term Debt | 1832.8 | 2055.1 | 2649.4 | 2882.8 | 2945.1 | 3166 |
| Long Term Debt | 1832.8 | 2055.1 | 2649.4 | 2882.8 | 2816.7 | 2988 |
| Deferred Income Tax | 41.4 | 31.7 | 32.5 | 74.4 | 94 | 164 |
| Minority Interest | 0 | |||||
| Other Liabilities, Total | 189.8 | 175 | 185.6 | 267.9 | 338.8 | 312 |
| Total Equity | 635.9 | 723.5 | 1086.7 | 2288.2 | 3505.4 | 4274 |
| Common Stock | 1.2 | 1.3 | 1.3 | 1.5 | 1.6 | 2 |
| Additional Paid-In Capital | 1976.5 | 1992 | 2283.3 | 2757.4 | 3818.7 | 4205 |
| Retained Earnings (Accumulated Deficit) | -1036.1 | -955.7 | -872.1 | -723.4 | -535.2 | 25 |
| Other Equity, Total | -305.7 | -324.6 | -324.7 | -304.8 | -385.2 | -316 |
| Total Liabilities & Shareholders’ Equity | 3091.1 | 3454.3 | 4531.1 | 6184 | 7776.5 | 9112 |
| Total Common Shares Outstanding | 124.712 | 125.05 | 133.424 | 145.7 | 162.8 | 170.5 |
| Korte Termijn Investeringen | 18.6 | 0 | 71 | |||
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | |
| Unrealized Gain (Loss) | 10.5 | -1.1 | -49.1 | -1.1 | -1 | |
| Redeemable Preferred Stock | 606.6 | 606.6 | 359 | |||
| Total Preferred Shares Outstanding | 0.65 | 0.65 | 0.38478 | |||
| Capital Lease Obligations | 128.4 | 178 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 2774.5 | 2918 | 3931 | 2974 | 3025 |
| Geldmiddelen en kortetermijnbeleggingen | 1062.8 | 967 | 2019 | 915 | 880 |
| Geldmiddelen & Equivalenten | 988.1 | 896 | 1969 | 849 | 786 |
| Korte Termijn Investeringen | 74.7 | 71 | 50 | 66 | 94 |
| Totale Vorderingen, Netto | 1012.3 | 1193 | 1055 | 1179 | 1259 |
| Accounts Receivable - Trade, Net | 1012.3 | 1193 | 1055 | 1179 | 1259 |
| Total Inventory | 555.1 | 593 | 653 | 709 | 697 |
| Prepaid Expenses | 107.2 | 118 | 151 | 110 | 133 |
| Other Current Assets, Total | 37.1 | 47 | 53 | 61 | 56 |
| Total Assets | 8769.1 | 9112 | 10183 | 10203 | 10322 |
| Property/Plant/Equipment, Total - Net | 2358.8 | 2608 | 2581 | 2727 | 2820 |
| Property/Plant/Equipment, Total - Gross | 3480.4 | 3787 | 3796 | 3982 | 4128 |
| Accumulated Depreciation, Total | -1121.6 | -1179 | -1215 | -1255 | -1308 |
| Goodwill, Net | 2515 | 2519 | 2531 | 3026 | 3012 |
| Intangibles, Net | 834.8 | 817 | 793 | 1132 | 1097 |
| Other Long Term Assets, Total | 286 | 250 | 347 | 344 | 368 |
| Total Current Liabilities | 1139.2 | 1196 | 1096 | 1045 | 1046 |
| Accounts Payable | 365.7 | 385 | 363 | 363 | 401 |
| Accrued Expenses | 351 | 401 | 346 | 362 | 390 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 73.6 | 75 | 79 | 29 | 29 |
| Other Current Liabilities, Total | 348.9 | 335 | 308 | 291 | 226 |
| Total Liabilities | 4696.9 | 4838 | 5803 | 5722 | 5690 |
| Total Long Term Debt | 3149.6 | 3166 | 4225 | 4191 | 4157 |
| Long Term Debt | 3149.6 | 2988 | 4225 | 4191 | 4157 |
| Deferred Income Tax | 100.3 | 164 | 171 | 189 | 211 |
| Other Liabilities, Total | 307.8 | 312 | 311 | 297 | 276 |
| Total Equity | 4072.2 | 4274 | 4380 | 4481 | 4632 |
| Redeemable Preferred Stock | 359 | 359 | 359 | 0 | 0 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 1.7 | 2 | 2 | 2 | 2 |
| Additional Paid-In Capital | 4185.7 | 4205 | 4234 | 4615 | 4630 |
| Retained Earnings (Accumulated Deficit) | -150.3 | 25 | 114 | 209 | 350 |
| Unrealized Gain (Loss) | -1.1 | -1 | -1 | -2 | -3 |
| Other Equity, Total | -322.8 | -316 | -328 | -343 | -347 |
| Total Liabilities & Shareholders’ Equity | 8769.1 | 9112 | 10183 | 10203 | 10322 |
| Total Common Shares Outstanding | 170.133 | 170.5 | 171 | 179 | 179 |
| Total Preferred Shares Outstanding | 0.38478 | 0.38478 | 0 | 0 | 0 |
| Capital Lease Obligations | 178 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | 111.2 | 109.8 | 83.6 | 137.4 | 220.7 | 585 |
| Geldmiddelen uit Operationele Activiteiten | 155.3 | 299.5 | 374.5 | 247.7 | 440.3 | 433 |
| Geldmiddelen uit Operationele Activiteiten | 140.6 | 146.5 | 190.1 | 228.6 | 253.7 | 289 |
| Deferred Taxes | -15.3 | -1.3 | 35.4 | -15.1 | 2.4 | 64 |
| Niet-Geldelijke Posten | 20.5 | 56.3 | 56.6 | 57.1 | 84.8 | -73 |
| Cash Taxes Paid | 40.6 | 39.8 | 23.9 | 42.2 | 43.4 | 47 |
| Contant Betaalde Rente | 82.4 | 80.8 | 83.2 | 102.5 | 98.4 | 105 |
| Veranderingen in het Operationeel Kapitaal | -101.7 | -11.8 | 8.8 | -160.3 | -121.3 | -432 |
| Geldmiddelen uit Investeringsactiviteiten | -137.7 | -309 | -919.3 | -1510.4 | -827.5 | -649 |
| Kapitaaluitgaven | -139.6 | -139.8 | -176.5 | -218.1 | -465.8 | -686 |
| Overige Cash Flow investeringsposten, Totaal | 1.9 | -169.2 | -742.8 | -1292.3 | -361.7 | 37 |
| Geldmiddelen uit Financieringsactiviteiten | -30.8 | 161.3 | 669.1 | 1201.4 | 1001.7 | 142 |
| Financiering van Cash Flow Posten | -14.5 | -11.8 | -29.3 | -39.3 | -56.9 | -55 |
| Uitgifte (Aflossing) van aandelen, netto | 0 | 0 | 277.8 | 1091.8 | 1046.5 | 120 |
| Uitgifte (Aflossing) van Schulden, Netto | -16.3 | 173.1 | 420.6 | 148.9 | 48.3 | 99 |
| Wisselkoerseffecten | -6.5 | 4.9 | -2.4 | -3.5 | -6.7 | 17 |
| Nettowijziging in Geldmiddelen | -19.7 | 156.7 | 121.9 | -64.8 | 607.8 | -57 |
| Total Cash Dividends Paid | -36.2 | -22 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 402.6 | 585 | 93 | 190 | 331 |
| Cash From Operating Activities | 298.7 | 433 | 163 | 232 | 370 |
| Cash From Operating Activities | 216 | 289 | 81 | 179 | 278 |
| Deferred Taxes | 17.8 | 64 | -8 | 1 | 13 |
| Non-Cash Items | -94.3 | -73 | 46 | 90 | 108 |
| Cash Taxes Paid | 24.8 | 47 | 15 | 27 | 40 |
| Cash Interest Paid | 97 | 105 | 40 | 50 | 93 |
| Changes in Working Capital | -243.4 | -432 | -49 | -228 | -360 |
| Cash From Investing Activities | -435.9 | -649 | -167 | -1299 | -1490 |
| Capital Expenditures | -497.1 | -686 | -154 | -277 | -425 |
| Other Investing Cash Flow Items, Total | 61.2 | 37 | -13 | -1022 | -1065 |
| Cash From Financing Activities | 159.3 | 142 | 1082 | 1033 | 1030 |
| Financing Cash Flow Items | -40.3 | -55 | -15 | -18 | -15 |
| Total Cash Dividends Paid | -17.7 | -22 | -4 | -4 | -4 |
| Issuance (Retirement) of Stock, Net | 103.9 | 120 | 8 | 19 | 21 |
| Issuance (Retirement) of Debt, Net | 113.4 | 99 | 1093 | 1036 | 1028 |
| Foreign Exchange Effects | 12.8 | 17 | -5 | -13 | -20 |
| Net Change in Cash | 34.9 | -57 | 1073 | -47 | -110 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 10.639 | 19146397 | 178443 | 2022-09-30 | LOW |
| T. Rowe Price Investment Management, Inc. | Investment Advisor | 10.2356 | 18420356 | 4856175 | 2022-09-30 | HIGH |
| Capital World Investors | Investment Advisor | 6.3398 | 11409408 | 1109522 | 2022-09-30 | LOW |
| Veritas Asset Management LLP | Investment Advisor/Hedge Fund | 6.2067 | 11169815 | 4212040 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0359 | 9062767 | 211705 | 2022-09-30 | LOW |
| Capital Research Global Investors | Investment Advisor | 4.3601 | 7813960 | 7813960 | 2022-06-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.9601 | 7126800 | 67054 | 2022-09-30 | LOW |
| Janus Henderson Investors | Investment Advisor/Hedge Fund | 3.7863 | 6813891 | -210135 | 2022-09-30 | LOW |
| Artisan Partners Limited Partnership | Investment Advisor | 3.2611 | 5868803 | 636031 | 2022-09-30 | LOW |
| Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 3.1373 | 5645971 | -15644 | 2022-09-30 | LOW |
| Leonard Green & Partners, L.P. | Private Equity | 2.4106 | 4338292 | 7830 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9485 | 3506644 | 79559 | 2022-09-30 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.8853 | 3392876 | 401891 | 2022-09-30 | LOW |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 1.7178 | 3091425 | -477166 | 2022-09-30 | LOW |
| JP Morgan Asset Management | Investment Advisor | 1.6948 | 3050107 | -385335 | 2022-09-30 | LOW |
| EARNEST Partners, LLC | Investment Advisor/Hedge Fund | 1.2444 | 2239391 | 46349 | 2022-09-30 | LOW |
| Carmignac Gestion | Investment Advisor/Hedge Fund | 0.9825 | 1768186 | 1128205 | 2022-09-30 | MED |
| T. Rowe Price Associates, Inc. | Investment Advisor | 0.9452 | 1701051 | -461899 | 2022-09-30 | LOW |
| Viking Global Investors LP | Investment Advisor/Hedge Fund | 0.9301 | 1673755 | -287494 | 2022-09-30 | |
| Bessemer Trust Company, N.A. (US) | Investment Advisor | 0.9176 | 1651393 | -17467 | 2022-09-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +500000+
Handelaren
93000+
Actieve klanten per maand
$57000000+
Maandelijks beleggingsvolume
$31000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Catalent Company profile
Over Catalent Inc
Catalent, Inc. levert toedieningstechnologieën en ontwikkelings- en productieoplossingen voor geneesmiddelen; biologische proteïne-, cel- en gentherapie; en gezondheidsproducten voor de consument. De segmenten omvatten softgel- en orale technologieën, biologische geneesmiddelen, orale en gespecialiseerde toediening, en klinische toeleveringsdiensten. Het segment Softgel- en orale technologieën houdt zich bezig met de formulering, ontwikkeling en productie van zachte capsules, alsook met de productie op grote schaal van orale vaste doseringsvormen. Het segment Biologics levert diensten op het gebied van de ontwikkeling en productie van biologische cellijnen, celtherapie en virale vector gentherapie. Het segment orale en speciale toedieningsvormen biedt formulatieontwikkeling en -productie aan via een waaier van technologieën, samen met geïntegreerde downstream klinische ontwikkeling en commerciële toeleveringsoplossingen. Het segment klinische toeleveringsdiensten houdt zich bezig met de productie, verpakking, distributie en voorraadbeheer voor geneesmiddelen en biologische geneesmiddelen in klinische studies.
| Industry: | Pharmaceuticals (NEC) |
14 Schoolhouse Rd
SOMERSET
NEW JERSEY 08873-1213
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 500.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen